Drugs / Almitrine
Almitrine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04357457 | Sep 2020 → Oct 2021 | COVID-19, respiratory failure | Assistance Publique - Hôpitaux de Paris | Completed | Missed primary |
Evidence & citations 13 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Almitrine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04357457 ↗ |
| Known as | Almitrina | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine bismesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine bismesylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine dimesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine dimesylate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine dimethanesulfonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Almitrine mesilate | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | ALMITRINE MESYLATE | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | S-2620 | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Known as | Vectarion | ChEMBL registry synonym — accepted as the source's own label CHEMBL1183717 ↗ |
| Modality | Small molecule | — CHEMBL1183717 ↗ |
| Route | Intravenous | “Intravenous almitrine” NCT04357457 ↗ |